Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, supplying promising breakthroughs throughout various professional medical and industrial apps. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, much more trusted substitute for therape